Forty years ago, hints of a new component of the immune system caused a stir. Here, we chart the story of gamma delta T cells from discovery to clinical trials…
To mark 20 years since the merger of the Cancer Research Campaign and the Imperial Cancer Research Fund, we’ve delved into the research of the charities’ that led to many of the drugs in use today.
How can we make the vital journey from research to clinical impact more efficient? It all comes down to empowering researchers to develop an entrepreneurial mindset
The director of our Cancer Research UK Edinburgh Centre walks us through some of his proudest research achievements and how supporters have made them possible.
Cancer Research UK and Hummingbird Bioscience announce a partnership to develop anti-HER3 antibody drug for the treatment of people with HER3 driven cancer
Cancer Research UK is partnering with two of Europe’s leading cancer research charities to fund six international projects worth a total of around £30 million.
The Zika virus can target and kill a particular type of brain tumour cell in the lab.
Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.
Advances in MRI technology could help scientists and doctors tailor cancer treatment by measuring the oxygen levels inside tumours.
Cancer Research UK has announced the largest investment to date into its network of Centres across the UK.